ARTICLE | Clinical News
Aeolus preclinical data
June 26, 2006 7:00 AM UTC
In a mouse model of PD, AEOL 11207 had oral bioavailability of 80%. The neuroprotectant crossed the blood brain barrier and protected dopamine neurons in a dose-dependent manner. Also, data suggested ...